These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31400346)

  • 21. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
    Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
    J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.
    Kaur K; Xiong J; Sawant N; Agarwal S; Hickey JM; Holland DA; Mukhopadhyay TK; Brady JR; Dalvie NC; Tracey MK; Love KR; Love JC; Weis DD; Joshi SB; Volkin DB
    J Pharm Sci; 2021 Mar; 110(3):1054-1066. PubMed ID: 33278412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
    Xue M; Yu L; Che Y; Lin H; Zeng Y; Fang M; Li T; Ge S; Xia N
    Vaccine; 2015 May; 33(22):2606-13. PubMed ID: 25882173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics.
    Rayfield WJ; Kandula S; Khan H; Tugcu N
    J Pharm Sci; 2017 Aug; 106(8):1944-1951. PubMed ID: 28343990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen.
    Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH
    Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical Characterization and Stabilization of a Lentiviral Vector Against Adsorption and Freeze-Thaw.
    Kumru OS; Wang Y; Gombotz CWR; Kelley-Clarke B; Cieplak W; Kim T; Joshi SB; Volkin DB
    J Pharm Sci; 2018 Nov; 107(11):2764-2774. PubMed ID: 30017889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation.
    Lang R; Winter G; Vogt L; Zurcher A; Dorigo B; Schimmele B
    Drug Dev Ind Pharm; 2009 Jan; 35(1):83-97. PubMed ID: 19016059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of porcine P[6], P[7]-specific △VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope.
    Wen X; Wei X; Ran X; Ni H; Cao S; Zhang Y
    Vaccine; 2015 Aug; 33(36):4533-9. PubMed ID: 26192360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze/thaw of IGG solutions.
    Horn J; Jena S; Aksan A; Friess W
    Eur J Pharm Biopharm; 2019 Jan; 134():185-189. PubMed ID: 30529434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG.
    Daneshmand B; Faghihi H; Amini Pouya M; Aghababaie S; Darabi M; Vatanara A
    Pharm Dev Technol; 2019 Apr; 24(4):439-447. PubMed ID: 30070161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities.
    Wang S; Zhang X; Wu G; Tian Z; Qian F
    Int J Pharm; 2017 Sep; 530(1-2):173-186. PubMed ID: 28755991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
    Izutsu KI
    Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design of heat stable lyophilized rotavirus vaccine formulations.
    Madan M; Sikriwal D; Sharma G; Shukla N; Mandyal AK; Kale S; Gill D
    Hum Vaccin Immunother; 2018; 14(9):2132-2141. PubMed ID: 29953317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.
    Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL
    Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries.
    Kumar P; Shukla RS; Patel A; Pullagurla SR; Bird C; Ogun O; Kumru OS; Hamidi A; Hoeksema F; Yallop C; Bines JE; Joshi SB; Volkin DB
    Hum Vaccin Immunother; 2021 Jul; 17(7):2298-2310. PubMed ID: 33861183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.